Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 32
Titolo Data di pubblicazione Autore(i) File
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 2010 Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J.
IS SURGICAL SPECIMEN QUALITY AFFECTED BY SURGEON EXPERIENCE? RESULTS AFTER 182 LAPAROSCOPIC PARTIAL NEPHRECTOMIES 2011 Fiori, C; Bertolo, R; Mele, Fabrizio; Manfredi, M; Distasio, A; SCARPA Roberto Mario, ; Bollito, E; Duregon, Eleonora; PAPOTTI Mauro Giulio, ; Porpiglia, Francesco
The weiss score and beyond--histopathology for adrenocortical carcinoma. 2011 Papotti M; Libè R; Duregon E; Volante M; Bertherat J; Tissier F.
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 2011 Duregon E; Volante M; Cappia S; Cuccurullo A; Bisceglia M; Wong DD; Spagnolo DV; Szpak-Ulczok S; Bollito E; Daffara F; Berruti A; Terzolo M; Papotti M.
PCA3 SCORE VALUE IS SIGNIFICANTLY RELATED TO GLEASON'S SCORE ON REPEAT PROSTATE BIOPSY AND RADICAL PROSTATECTOMY SPECIMENS 2012 Bollito E; De Luca S; Di Stasio A; Passera R; Milillo A; Duregon E; Fornari A; Porpiglia F; Randone DF; Papotti M
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 2013 Duregon E; Volante M; Giorcelli J; Terzolo M; Lalli E; Papotti M
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 2013 Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M.
THE PROGNOSTIC ROLE OF MOLECULAR TESTING IN PATIENTS WITH PROSTATE CANCER: A PRELIMINARY STUDY 2013 Bollito E; Manfredi M; Duregon E; Freschi M; Scattoni V; Papotti M; Porpiglia F
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 2014 Eleonora Duregon;Luca Molinaro;Marco Volante;Laura Ventura;Luisella Righi;Stefania Bolla;Massimo Terzolo;Anna Sapino;Mauro G Papotti
ELOVL5 Mutations Cause Spinocerebellar Ataxia 38 2014 Eleonora Di Gregorio;Barbara Borroni;Elisa Giorgio;Daniela Lacerenza;Marta Ferrero;Nicola Lo Buono;Neftj Ragusa;Cecilia Mancini;Marion Gaussen;Alessandro Calcia;Nico Mitro;Eriola Hoxha;Isabella Mura;Domenico A. Coviello;Young-Ah Moon;Christelle Tesson;Giovanna Vaula;Philippe Couarch;Laura Orsi;Eleonora Duregon;Mauro Giulio Papotti;Jean-François Deleuze;Jean Imbert;Chiara Costanzi;Alessandro Padovani;Paola Giunti;Marcel Maillet-Vioud;Alexandra Durr;Alexis Brice;Filippo Tempia;Ada Funaro;Loredana Boccone;Donatella Caruso;Giovanni Stevanin;Alfredo Brusco
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 2014 Volante M; Birocco N;Gatti G; Duregon E; lorizzo K; Fazio N; Scagliotti GV; Papotti M
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 2014 Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M.
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 2014 Papotti M; Duregon E; Volante M; McNicol AM.
Pitfalls in the diagnosis of adrenocortical tumors: A lesson from 300 consultation cases 2015 Duregon, Eleonora; Volante, Marco; Bollito, Enrico; Goia, Margherita; Buttigliero, Consuelo; Zaggia, Barbara; Berruti, Alfredo; Scagliotti, Giorgio Vittorio; Papotti, Mauro
Better see to better agree: Phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds 2015 Duregon, Eleonora; Cassenti, Adele; Pittaro, Alessandra; Ventura, Laura; Senetta, Rebecca; Rudà, Roberta; Cassoni, Paola
YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study 2015 Rebecca Senetta;Eleonora Duregon;Cristina Sonetto;Rossella Spadi;Massimiliano Mistrangelo;Patrizia Racca;Luigi Chiusa;Fernando H. Munoz;Umberto Ricardi;Alberto Arezzo;Adele Cassenti;Isabella Castellano;Mauro Papotti;Mario Morino;Mauro Risio;Paola Cassoni
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 2015 Ardito, A; Massaglia, C; Pelosi, E; Zaggia, B; Basile, V; Brambilla, R; Vigna-Taglianti, F; Duregon, E; Arena, V; Perotti, P; Penna, D; Terzolo, M.
Dissecting morphological and molecular heterogeneity in adrenocortical carcinoma 2015 Duregon, Eleonora; Volante, Marco; Rapa, Ida; Vatrano, Simona; Papotti, Mauro
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 2015 Duregon, Eleonora; Senetta, Rebecca; Pittaro, Alessandra; Verdun di Cantogno, Ludovica; Stella, Giulia; De Blasi, Pierpaolo; Zorzetto, Michele; Mantovani, Cristina; Papotti, Mauro; Cassoni, Paola
Percentage of positive prostate biopsies independently predicts biochemical outcome following radiation therapy for prostate cancer 2016 Gabriele, Domenico; Garibaldi, Monica; Girelli, Giuseppe; Taraglio, Stefano; Duregon, Eleonora; Gabriele, Pietro; Guiot, Caterina; Bollito, Enrico
Mostrati risultati da 1 a 20 di 32
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile